Showing results 1 to 5 of 5
A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques Jung, Kyung Hee; Ryu, Ye-Lim; Lee, Hee-Seung; Lee, Hyunseung; Son, Mi Kwon; Yan, Hong Hua; Hong, Sang-Won; et al, INTERNATIONAL JOURNAL OF ONCOLOGY, v.42, no.6, pp.2001 - 2008, 2013-06 |
Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer Seo, Ju Hyeon; Jung, Kyung Hee; Son, Mi Kwon; Yan, Hong Hua; Ryu, Ye-Lim; Kim, Jinhee; Lee, Jung Kyun; et al, CANCER LETTERS, v.338, no.2, pp.271 - 281, 2013-09 |
Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells Ryu, Ye-Lim; Jung, Kyung Hee; Son, Mi Kwon; Yan, Hong Hua; Kim, Soo Jung; Shin, Sang Hye; Hong, Sungwoo; et al, CANCER LETTERS, v.353, no.1, pp.68 - 77, 2014-10 |
HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis![]() Son, Mi Kwon; Ryu, Ye-Lim; Jung, Kyung Hee; Lee, Hyunseung; Lee, Hee Seung; Yan, Hong Hua; Park, Heon Joo; et al, SCIENTIFIC REPORTS, v.3, 2013-12 |
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation![]() Kim, Soo Jung; Jung, Kyung Hee; Yan, Hong Hua; Son, Mi Kwon; Fang, Z; Ryu, Ye-Lim; Lee, Hyunseung; et al, ONCOTARGET, v.6, no.3, pp.1507 - 1518, 2015-01 |
Discover